comparemela.com

Latest Breaking News On - Generation bio - Page 4 : comparemela.com

Moderna (MRNA) Q1 2024 Earnings Call Transcript

MRNA earnings call for the period ending March 31, 2024.

United statesNew yorkMichael yeeGena wang barclaysGeoff meachamSimon bakerJessica fye jpmorganTed tenthoff piper sandlerTerence flynnEdward tenthoffTerence flynn morgan stanleyJessica fyeEvan wang guggenheimHartaj singhMike yee jefferiesLavina talukdar

Generation Bio Co (NASDAQ:GBIO) Given Average Recommendation of Hold by Analysts

Generation Bio Co. (NASDAQ:GBIO – Get Free Report) has earned an average rating of “Hold” from the six research firms that are currently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1-year price target […]

Los angelesUnited statesPanagora asset management incSg americas securitiesLos angeles capital managementTd asset management incGeneration bio coKestra private wealth servicesNeedham companyGeneration bioGet free reportMarketbeat ratingsManagement incPrivate wealth servicesAngeles capital managementPanagora asset management

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates

EQS-News: BB BIOTECH AG / Key word: Interim Report BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates.

Maria grazia alderuccioErich hunzikerKrogsgaard thomsenThomas eggerPearl huangClive meanwellEssa pharmaCamilla soenderbyClaude mikkelsenLaura hamillSilvia siegfried schanzNeurocrine biosciencesTanja chicherioAgios pharmaceuticalsAlnylam pharmaceuticalsGeneration bio co

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

22.04.2024 - CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) - Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts highlighting .

Maren killackeyHighly specificVivo deliveryCell targeted lipidTargeting specific cell typesImmunological responsesNonviral therapeutic gene deliveryGeneration bio

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

CAMBRIDGE, Mass., April 22, 2024 Generation Bio Co. a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts.

United statesUnited kingdomMatt stantonMaren killackeyDevelopment of cellGeneration bio coAmerican society of geneAmerican societyCell therapyAnnual meetingHighly specificVivo deliveryCell targeted lipidTargeting specific cell typesImmunological responsesEnzymatic synthesis

vimarsana © 2020. All Rights Reserved.